ASX Limited

Market Announcements Office

Change of Registered Office and Principal Place of Business

20 January 2017, Melbourne: Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), wishes to advise that its registered office, principal place of business and postal address have changed, with immediate effect to:

Unit A8, 2A Westall Road Clayton Victoria 3168

Phone: +61 3 9002 5000

Enquiries

Anna Legg Company Secretary

Kyahn Williamson WE Buchan

+61 3 9866 4722 / +61 401 018 828

Email: kwilliamson@buchanwe.com.au

About Phosphagenics

Phosphagenics Limited is focused on developing and commercialising innovative Human Health, Animal Health and Personal Care products using its proprietary drug delivery system called TPM® (Targeted Penetration Matrix). TPM® is derived from Vitamin E using a unique, proprietary and patented process and has been proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients.

Amongst its major projects, Phosphagenics' is developing TPM® enhanced patches, gels and injectable products for the human health market and is also developing TPM® to enhance the feed efficiency and health of livestock.

Phosphagenics' shares are listed on the Australian Securities Exchange (POH) and its ADR - Level 1 program in the US is with The Bank of New York Mellon (PPGNY).

Phosphagenics Limited

ACN 056 482 403 ABN 32 056 482 403

Unit A8, 2A Westall Road, Clayton VIC 3168. Australia

Tel: +61 3 9002 5000

www.phosphagenics.com Email: info@phosphagenics.com

Phosphagenics Ltd. published this content on 20 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 January 2017 04:18:04 UTC.

Original documenthttp://www.phosphagenics.com/wp-content/uploads/2017/01/2017-Jan-20-Change-Registered-Office-and-Principal-Place-Business.pdf

Public permalinkhttp://www.publicnow.com/view/6F58271A9C90C05EEE2F12F935F4DC17C79EC780